Kiniksa Pharmaceuticals, Ltd. KNSA

$ 21.04 -0.8%

Quarterly report 2024-Q3
added 10-29-2024

Kiniksa Pharmaceuticals, Ltd. Financial Statements 2011-2024 | KNSA

Annual Financial Statements Kiniksa Pharmaceuticals, Ltd.

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	1.43 B	868 M	770 M	1.22 B	800 M	904 M	-	-	-	-	-	-	-
Shares	70.1 M	69.4 M	68.6 M	61.8 M	54 M	49.5 M	-	-	-	-	-	-	-
Historical Prices	20.4	12.5	11.2	19.7	14.7	17.5	-	-	-	-	-	-	-
Net Income	14.1 M	183 M	-158 M	-161 M	-162 M	-103 M	-64.9 M	-24 M	-	-	-	-	-
Revenue	270 M	220 M	38.5 M	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-25.2 M	9.77 M	-157 M	-157 M	-170 M	-108 M	-65.4 M	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-22.9 M	12.2 M	-154 M	-155 M	-168 M	-108 M	-65.4 M	-24 M	-	-	-	-	-
Operating Expenses	-	-	-	-	170 M	108 M	-	-	-	-	-	-	-
General and Administrative Expenses	129 M	98 M	85.9 M	45.3 M	35 M	21.6 M	9.04 M	6.56 M	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Kiniksa Pharmaceuticals, Ltd.

	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	71.7 M	71 M	70.6 M	70.2 M	69.9 M	69.8 M	-	69.4 M	69.3 M	69.1 M	-	68.7 M	68.4 M	68.3 M	-	66 M	57.9 M	55.3 M	-	54.8 M	54.5 M	51.8 M	-	48.2 M	18.3 M	2.48 M	-	1.94 M	1.67 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-12.7 M	-3.91 M	-17.7 M	-13.9 M	15 M	-12.3 M	-	224 M	-20 M	-25.2 M	-	-30.5 M	-41.6 M	-49.5 M	-	-43.8 M	-37.5 M	-26.4 M	-	-27.1 M	-37.2 M	-65.8 M	-	-24.4 M	-20.3 M	-16 M	-	-16 M	-11.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	112 M	109 M	79.9 M	67 M	71.5 M	48.3 M	-	99.1 M	27 M	32.2 M	-	12.1 M	7.7 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	20.1 M	12.3 M	10.6 M	9.09 M	7.7 M	7.04 M	-	6.94 M	5.03 M	-	-	2.77 M	2.47 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-9.66 M	-117 K	-16.5 M	-10.9 M	-3.15 M	-11.2 M	-	46.4 M	-19.4 M	-23.3 M	-	-30.7 M	-40.6 M	-49.3 M	-	-43.2 M	-31.9 M	-29.4 M	-	-30.4 M	-39.3 M	-67.6 M	-	-26.2 M	-21.5 M	-16.3 M	-	-16.2 M	-11.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-9.57 M	2 K	-16.1 M	-10.6 M	-2.86 M	-10.6 M	-	46.6 M	-19 M	-22.7 M	-	-29 M	-40.1 M	-49 M	-	-41.4 M	-30.7 M	-28.8 M	-	-29.9 M	-38.8 M	-67.2 M	-	-26.1 M	-21.5 M	-16.3 M	-	-16.2 M	-11.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	49.3 M	-	43.2 M	31.9 M	29.4 M	-	30.4 M	39.3 M	67.6 M	-	26.2 M	21.5 M	16.3 M	-	16.2 M	11.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	46.4 M	42.4 M	38.7 M	34.5 M	29.2 M	29 M	-	24.7 M	23.8 M	22.2 M	-	20.8 M	21.8 M	20.6 M	-	11.8 M	9.54 M	8.49 M	-	8.43 M	8.44 M	8.39 M	-	5.52 M	4.33 M	3.71 M	-	2.24 M	2.12 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency